Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,192 | -9,151 | -25,788 | -17,647 | -10,898 |
| Depreciation Amortization | 125 | 58 | 252 | 186 | 121 |
| Accounts receivable | -1,818 | 420 | 2,391 | 2,034 | 1,279 |
| Accounts payable and accrued liabilities | 1,348 | -377 | 2,440 | 1,837 | 1,165 |
| Other Working Capital | 313 | 483 | 4,846 | 3,298 | 1,846 |
| Other Operating Activity | 2,983 | 1,323 | -159 | -270 | 86 |
| Operating Cash Flow | $-13,241 | $-7,244 | $-16,018 | $-10,562 | $-6,401 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | -147 | -117 | -59 |
| Investing Cash Flow | $-3 | $N/A | $-147 | $-117 | $-59 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,342 | 12,277 | 5,332 | 2,714 | 2,502 |
| Other Financing Activity | -487 | -284 | -811 | -632 | -417 |
| Financing Cash Flow | $11,855 | $11,993 | $4,521 | $2,082 | $2,085 |
| Exchange Rate Effect | N/A | N/A | 4 | 4 | 3 |
| Beginning Cash Position | 29,922 | 29,922 | 41,562 | 41,562 | 41,562 |
| End Cash Position | 28,533 | 34,671 | 29,922 | 32,969 | 37,190 |
| Net Cash Flow | $-1,389 | $4,749 | $-11,640 | $-8,593 | $-4,372 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,241 | -7,244 | -16,018 | -10,562 | -6,401 |
| Capital Expenditure | -3 | N/A | -147 | -117 | -59 |
| Free Cash Flow | -13,244 | -7,244 | -16,165 | -10,679 | -6,460 |